Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Applied Genetic Technologies Corporation (AGTC)

5.06   0.2 (4.12%) 10-01 14:45
Open: 4.91 Pre. Close: 4.86
High: 5.1 Low: 4.8
Volume: 285,797 Market Cap: 131M
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The company is headquartered in Alachua, Florida and currently employs 85 full-time employees. The firm develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The firm is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.023 - 5.049 5.049 - 5.068
Low: 4.742 - 4.768 4.768 - 4.788
Close: 4.818 - 4.862 4.862 - 4.896

Technical analysis

as of: 2020-10-01 2:30:28 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 6.60     One year: 7.56
Support: Support1: 4.32    Support2: 3.59
Resistance: Resistance1: 5.65    Resistance2: 6.47
Pivot: 4.95
Moving Average: MA(5): 4.93     MA(20): 5.12
MA(100): 5.37     MA(250): 4.63
MACD: MACD(12,26): -0.12     Signal(9): -0.13
Stochastic oscillator: %K(14,3): 45.87     %D(3): 37.71
RSI: RSI(14): 48.40
52-week: High: 10.42  Low: 2.29  Change(%): 43.1
Average Vol(K): 3-Month: 30386  10-Days: 20093

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AGTC has closed below upper band by 41.1%. Bollinger Bands are 17.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
How High Can Applied Genetic Technologies Corporation (AGTC) Reach? - investmillion.com

Wed, 23 Sep 2020
Applied Genetic Technologies Corporation (AGTC) Plunges 5.06% on September 23 - equities.com

Wed, 23 Sep 2020
Applied Genetic Technologies (NASDAQ:AGTC) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Sat, 12 Sep 2020
Could The Applied Genetic Technologies Corporation (NASDAQ:AGTC) Ownership Structure Tell Us Something Useful? - Yahoo Finance

Fri, 11 Sep 2020
AGTC outlines plans for phase 2/3 X-linked retinitis pigmentosa trial - Healio

Wed, 09 Sep 2020
Applied Genetic Technologies (AGTC) Provides Trial Design Update for its Phase 2/3 XLRP Clinical Trial, New Data on XLRP Higher Dose Group and Financial Results - StreetInsider.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26
Shares Float (M) 23
% Held by Insiders 0.93
% Held by Institutions 48.19
Shares Short (K) 1,350
Shares Short P. Month (K) 2,760

Stock Financials

EPS -2.175
EPS Est This Year -0.810
EPS Est Next Year -1.640
Book Value (p.s.) 2.750
Profit Margin
Operating Margin -1913.66
Return on Assets (ttm) -30.5
Return on Equity (ttm) -61.3
Qtrly Rev. Growth -100.0
Gross Profit (p.s.) -0.540
Sales Per Share 0.095
EBITDA (p.s.) -1.769
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio -2.32
PEG Ratio
Price to Book value 1.84
Price to Sales 53.16
Price to Cash Flow -3.13

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.